The Use of the Red Cell Surface Antigen to Predict the Malignant Potential of Transitional Cell Carcinoma of the Ureter and Renal Pelvis
- 1 January 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 127 (1) , 23-25
- https://doi.org/10.1016/s0022-5347(17)53582-x
Abstract
This is the 1st report on the use of the red cell surface antigen test in predicting the malignant potential of transitional cell carcinoma of the ureter and renal pelvis. In 29 [human] cases evaluated there was an 80% correlation. The red cell surface antigen determination evidently had practical value in the management of these tumors.This publication has 9 references indexed in Scilit:
- The Cell Surface Antigens of Bladder Washing Specimens in Patients with Bladder Tumors, A New ApproachJournal of Urology, 1980
- Immunologic Indicators of Prognosis in Bladder Cancer: The Importance of Cell Surface AntigensJournal of Urology, 1980
- The Prognostic Value of Cell Surface Antigens in Low Grade, Non-Invasive, Transitional Cell Carcinoma of the BladderJournal of Urology, 1979
- Conservative surgical management for noninvasive distal ureteral carcinomaUrology, 1979
- Tissue Blood-Group Antigens and Prognosis in Low Stage Transitional Cell Carcinoma of the BladderJournal of Urology, 1978
- The Cell Surface Antigen A, B or O(h) as an Indicator of Malignant Potential in Stage a Bladder Carcinoma: Preliminary ReportJournal of Urology, 1978
- Antigenic Deletion and Prognosis of Patients with Stage a Transitional Cell Bladder CarcinomaJournal of Urology, 1975
- Early Immunologic Diagnosis and Prognosis of Carcinoma:Philip Levine Award AddressAmerican Journal of Clinical Pathology, 1972
- A and B Antigens of Normal and Malignant CellsBritish Journal of Cancer, 1957